Skip to content
McCall Hamilton Advocacy and Public Affairs

Updates About Public Health

Potential Federal Reclassification of Marijuana: Implications for Research and Medicine

Update: Apr 30-May 10, 2024

The federal government may soon reclassify marijuana, potentially easing restrictions in the medical research sphere. If classified as a Schedule III substance, marijuana would join drugs like codeine and ketamine in requiring a doctor’s prescription. This shift could significantly impact opportunities for research, making it easier for scientists to conduct studies and access funding. This is especially relevant in states like Michigan, where medicinal and recreational use has already been legalized.

Currently, the federal classification lists marijuana as a Schedule I substance, which poses a significant barrier to conducting research on marijuana’s effects and health implications. With reclassification, access to research opportunities and the ability to explore marijuana’s potential medical benefits could expand. Despite a possible federal change, immediate impacts on state regulations may be limited.

Audit Initiated in Response to Concerns Surrounding Youth Psychiatric Center

Update: Apr 16-29, 2024

Recent controversies surrounding Michigan’s state-run youth psychiatric services, including lawsuits, patient escapes, and allegations of inadequate care, have prompted the initiation of an audit by the Office of the Auditor General (OAG). Specifically, the Office of Recipient Rights (ORR), responsible for safeguarding the rights of mental health service recipients, is under review.

Sen. Michael Webber (R – Rochester Hills) and colleagues requested the audit last year amidst concerns about management practices at facilities like the Hawthorn Center in Northville. Complaints of substandard care, including allegations of physical abuse and poor living conditions, have underscored the need for transparency and accountability in state-operated psychiatric hospitals. The audit, expected to take approximately six months, aims to identify systemic issues and promote improvements in patient care and oversight protocols. Despite some scrutiny over its handling of the situation, MDHHS asserts that it is fully supportive of transparency efforts.

As investigations unfold, necessary reforms are anticipated to ensure the well-being of vulnerable youth under state care.

Medicaid Health Plan Rebid: Changes in the Coverage Landscape

Update: Apr 1-15, 2024

In the recent Medicaid health plan rebid by Michigan’s Department of Health and Human Services, significant changes have reshaped coverage across the state’s ten regions. Blue Cross Blue Shield of Michigan emerged as the primary beneficiary, expanding its territory across various regions. The rebid, a key part of Governor Whitmer’s 2024-2025 fiscal year budget recommendation, will prioritize equitable, person-centered care for the nearly two million Medicaid beneficiaries. Additionally, revisions to the payment structure include withholding a greater percentage of funds to incentivize improved health outcomes and address social determinants of health.

The rebid resulted in a redistribution of territories among nine health plans, with Blue Cross Blue Shield of Michigan gaining ground in several regions. Notably, McLaren emerged as the sole plan in nine of the ten regions, while Blue Cross now has a presence in seven regions, marking significant shifts in coverage landscape.

At this time, the contracts are not yet secured in place. The new contracts are scheduled to come into effect on October 1 of this year.